Risk Of Developing Liver Cancer After HCV Treatment

▼
Showing posts with label boceprevir-victrelis. Show all posts
Showing posts with label boceprevir-victrelis. Show all posts
Tuesday, January 20, 2015

Hepatitis C Infection Treatment Will Be Discontinued

›
Hepatitis C Infection Treatment Will Be Discontinued The Food and Drug Administration (FDA) is informing that Victrelis (boceprevir; Merck...
Wednesday, October 1, 2014

Hepatitis C:Drug–drug interaction (DDI) may not be reflected in prescribing information

›
Medication use and medical comorbidity in patients with chronic hepatitis C  The latest issue of the European Journal of Gastroenterolog...
Wednesday, February 12, 2014

Hepatitis - FDA Label update for Victrelis (boceprevir)

›
The Victrelis (boceprevir) label has been updated to include the following information under Section 5 Warnings and Precautions: 5.4 ...
Monday, December 9, 2013

Boceprevir vs Telaprevir: Comparison of Hepatitis C virus protease inhibitors in the USA

›
Comparison of Hepatitis C virus protease inhibitors in the USA Full Text Available, here The most recent issue of the Alimentary Pharmaco...
Monday, October 21, 2013

Triple therapy effective in cirrhotic patients with HIV/HCV

›
Joop Arends, MD, PhD, an infectious disease specialist at the University Medical Center Utrecht in the Netherlands, discusses his present...
Tuesday, September 24, 2013

Real-world SVR rate about 33% with hepatitis C triple therapy

›
Real-world SVR rate about 33% with hepatitis C triple therapy By: M. ALEXANDER OTTO, Family Practice News Digital Network DENVER – On...
Tuesday, August 20, 2013

Treatment approaches- Treat HCV now or wait and management of adverse events

›
Hi Folks, When a new HCV  learning activity is released online this blog provides background information, and links to the new video, arti...
Sunday, August 4, 2013

Hepatitis C- High discontinuation rate noted for direct-acting antiviral therapy

›
High discontinuation rate noted for direct-acting antiviral therapy By: DENISE NAPOLI, IMNG Medical News Despite high rates of early cli...

Triple therapy underutilized in HCV

›
Triple therapy underutilized in HCV   By: DENISE NAPOLI, IMNG Medical News Fewer than 20% of patients with hepatitis C virus genotype 1 rece...
Monday, July 22, 2013

Management of anemia induced by triple therapy in patients with chronic hepatitis C

›
Management of anemia induced by triple therapy in patients with chronic hepatitis C: challenges, opportunities and recommendations Manuel ...

Hepatitis C- Are Patients Receiving the Latest Anti-HCV Drugs?

›
Are Patients Receiving the Latest Anti-HCV Drugs? Posted on July 22, 2013 by Kristine Novak, PhD, Science Editor Less than 20% of patien...
Thursday, July 11, 2013

Video Vignettes -Current Outlook On Hepatitis C Treatment

›
When a new learning activity pertaining to HCV is released online this blog provides readers with background information and links to th...
Friday, July 5, 2013

Boceprevir- Adherence to Assigned Dosing Regimen in Chronic Hepatitis C

›
Adherence to Assigned Dosing Regimen in Chronic Hepatitis C Discussion Only Abstract and Introduction Materials and Methods Results ...
Thursday, July 4, 2013

Hepatitis C Triple Therapy Scores in Large Clinical Trial

›
July Infectious disease special edition Hepatitis C Triple Therapy Scores in Large Clinical Trial by Christina Frangou Patients with the...
Saturday, June 29, 2013

Hope for HCV Patients Who Failed Therapy With Telaprevir or Boceprevir

›
Clinical Care Options Hope for HCV Patients Who Failed Therapy With Telaprevir or Boceprevir Mark S. Sulkowski, MD - 6/28/2013 *Free r...
Thursday, June 27, 2013

Healio: HCV triple therapy post-liver transplant yields moderate response, significant adverse events

›
HCV triple therapy post-liver transplant yields moderate response, significant adverse events June 27, 2013 Liver transplant recipients...
Sunday, June 23, 2013

Webcast - Managing Rashes Associated with Anti-HCV Triple Therapy

›
When a new  educational resource is released online this blog provides readers with background information and links to the new activity....
Thursday, June 20, 2013

SVR after triple therapy maintained long-term durability in HCV patients

›
SVR after triple therapy maintained long-term durability in HCV patients Rutter K. Aliment Pharmacol Ther. 2013;38:118-123. Source - Hea...
Tuesday, June 4, 2013

After HCV treatment failure, some success with boceprevir-IFN-ribavirin

›
After HCV treatment failure, some success with boceprevir-IFN-ribavirin By: NEIL OSTERWEIL, Internal Medicine News Digital Network ORLA...
Thursday, May 16, 2013

Triple therapy for hepatitis C is effective after liver transplantation, but side-effects are common

›
Triple therapy for hepatitis C is effective after liver transplantation, but side-effects are common Liz Highleyman Produced in collabo...